Jiangsu, China

Rong Yin

This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hengrui Medicine Company Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rong Yin. Retrieved from https://idiyas.com/inventor/rong-yin-w402lrnc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rong Yin - Innovator in Pharmaceutical Composition

Introduction

Rong Yin is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions. His work focuses on enhancing the quality and stability of pharmaceutical products.

Latest Patents

Rong Yin holds a patent for a trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use. This innovative composition includes trabectedin and a first excipient, which is selected from one or more of monosaccharides or polyols. The preparation method described in his patent ensures stable quality and is suitable for mass production.

Career Highlights

Rong Yin is associated with Jiangsu Hengrui Medicine Company Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the company's product offerings and enhancing therapeutic options for patients.

Collaborations

Rong Yin collaborates with talented professionals in his field, including Likun Wang and Qiong Sun. Their combined efforts contribute to the innovative environment at Jiangsu Hengrui Medicine Company Ltd.

Conclusion

Rong Yin's contributions to pharmaceutical innovation, particularly through his patented compositions, highlight his role as a key figure in the industry. His work not only advances medical science but also improves patient care through effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…